Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Integra Lifesciences Holdings (IART) over the last 15 years, with Q3 2025 value amounting to -$17.0 million.

  • Integra Lifesciences Holdings' Gains from Investment Securities fell 1004444.44% to -$17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.8 million, marking a year-over-year decrease of 39820.89%. This contributed to the annual value of -$5.8 million for FY2024, which is 14493.33% down from last year.
  • Integra Lifesciences Holdings' Gains from Investment Securities amounted to -$17.0 million in Q3 2025, which was down 1004444.44% from $225000.0 recorded in Q2 2025.
  • Integra Lifesciences Holdings' 5-year Gains from Investment Securities high stood at $14.0 million for Q2 2022, and its period low was -$17.0 million during Q3 2025.
  • Moreover, its 5-year median value for Gains from Investment Securities was $850000.0 (2023), whereas its average is $1.2 million.
  • As far as peak fluctuations go, Integra Lifesciences Holdings' Gains from Investment Securities skyrocketed by 666328.5% in 2022, and later crashed by 1004444.44% in 2025.
  • Quarter analysis of 5 years shows Integra Lifesciences Holdings' Gains from Investment Securities stood at $515000.0 in 2021, then crashed by 47.18% to $272000.0 in 2022, then surged by 1594.85% to $4.6 million in 2023, then plummeted by 298.81% to -$9.2 million in 2024, then plummeted by 85.54% to -$17.0 million in 2025.
  • Its last three reported values are -$17.0 million in Q3 2025, $225000.0 for Q2 2025, and $2.1 million during Q1 2025.